Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-Analysis

Meta-analyses have been extensively used to evaluate the efficacy of neurofeedback (NFB) treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. However, each meta-analysis published in the past decade has contradicted the methods and results from the previous one,...

Full description

Bibliographic Details
Main Authors: Aurore Bussalb, Marco Congedo, Quentin Barthélemy, David Ojeda, Eric Acquaviva, Richard Delorme, Louis Mayaud
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Psychiatry
Subjects:
EEG
Online Access:https://www.frontiersin.org/article/10.3389/fpsyt.2019.00035/full
id doaj-ef4ac4d9973343ef832b44ab8c158111
record_format Article
spelling doaj-ef4ac4d9973343ef832b44ab8c1581112020-11-25T00:11:44ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402019-02-011010.3389/fpsyt.2019.00035425806Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-AnalysisAurore Bussalb0Aurore Bussalb1Marco Congedo2Quentin Barthélemy3David Ojeda4Eric Acquaviva5Richard Delorme6Louis Mayaud7Mensia Technologies SA, Paris, FranceChild and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, FranceGIPSA-Lab, Université Grenoble Alpes, CNRS, Grenoble-INP, Grenoble, FranceMensia Technologies SA, Paris, FranceMensia Technologies SA, Paris, FranceChild and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, FranceChild and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, FranceMensia Technologies SA, Paris, FranceMeta-analyses have been extensively used to evaluate the efficacy of neurofeedback (NFB) treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. However, each meta-analysis published in the past decade has contradicted the methods and results from the previous one, thus making it difficult to determine a consensus of opinion on the effectiveness of NFB. This works brings continuity to the field by extending and discussing the last and much controversial meta-analysis by Cortese et al. (1). The extension comprises an update of that work including the latest control trials, which have since been published and, most importantly, offers a novel methodology. Specifically, NFB literature is characterized by a high technical and methodological heterogeneity, which partly explains the current lack of consensus on the efficacy of NFB. This work takes advantage of this by performing a Systematic Analysis of Biases (SAOB) in studies included in the previous meta-analysis. Our extended meta-analysis (k = 16 studies) confirmed the previously obtained results of effect sizes in favor of NFB efficacy as being significant when clinical scales of ADHD are rated by parents (non-blind, p-value = 0.0014), but not when they are rated by teachers (probably blind, p-value = 0.27). The effect size is significant according to both raters for the subset of studies meeting the definition of “standard NFB protocols” (parents' p-value = 0.0054; teachers' p-value = 0.043, k = 4). Following this, the SAOB performed on k = 33 trials identified three main factors that have an impact on NFB efficacy: first, a more intensive treatment, but not treatment duration, is associated with higher efficacy; second, teachers report a lower improvement compared to parents; third, using high-quality EEG equipment improves the effectiveness of the NFB treatment. The identification of biases relating to an appropriate technical implementation of NFB certainly supports the efficacy of NFB as an intervention. The data presented also suggest that the probably blind assessment of teachers may not be considered a good proxy for blind assessments, therefore stressing the need for studies with placebo-controlled intervention as well as carefully reported neuromarker changes in relation to clinical response.https://www.frontiersin.org/article/10.3389/fpsyt.2019.00035/fullADHDneurofeedbackmeta-analysisanalysis of biasEEG
collection DOAJ
language English
format Article
sources DOAJ
author Aurore Bussalb
Aurore Bussalb
Marco Congedo
Quentin Barthélemy
David Ojeda
Eric Acquaviva
Richard Delorme
Louis Mayaud
spellingShingle Aurore Bussalb
Aurore Bussalb
Marco Congedo
Quentin Barthélemy
David Ojeda
Eric Acquaviva
Richard Delorme
Louis Mayaud
Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-Analysis
Frontiers in Psychiatry
ADHD
neurofeedback
meta-analysis
analysis of bias
EEG
author_facet Aurore Bussalb
Aurore Bussalb
Marco Congedo
Quentin Barthélemy
David Ojeda
Eric Acquaviva
Richard Delorme
Louis Mayaud
author_sort Aurore Bussalb
title Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-Analysis
title_short Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-Analysis
title_full Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-Analysis
title_fullStr Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-Analysis
title_full_unstemmed Clinical and Experimental Factors Influencing the Efficacy of Neurofeedback in ADHD: A Meta-Analysis
title_sort clinical and experimental factors influencing the efficacy of neurofeedback in adhd: a meta-analysis
publisher Frontiers Media S.A.
series Frontiers in Psychiatry
issn 1664-0640
publishDate 2019-02-01
description Meta-analyses have been extensively used to evaluate the efficacy of neurofeedback (NFB) treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. However, each meta-analysis published in the past decade has contradicted the methods and results from the previous one, thus making it difficult to determine a consensus of opinion on the effectiveness of NFB. This works brings continuity to the field by extending and discussing the last and much controversial meta-analysis by Cortese et al. (1). The extension comprises an update of that work including the latest control trials, which have since been published and, most importantly, offers a novel methodology. Specifically, NFB literature is characterized by a high technical and methodological heterogeneity, which partly explains the current lack of consensus on the efficacy of NFB. This work takes advantage of this by performing a Systematic Analysis of Biases (SAOB) in studies included in the previous meta-analysis. Our extended meta-analysis (k = 16 studies) confirmed the previously obtained results of effect sizes in favor of NFB efficacy as being significant when clinical scales of ADHD are rated by parents (non-blind, p-value = 0.0014), but not when they are rated by teachers (probably blind, p-value = 0.27). The effect size is significant according to both raters for the subset of studies meeting the definition of “standard NFB protocols” (parents' p-value = 0.0054; teachers' p-value = 0.043, k = 4). Following this, the SAOB performed on k = 33 trials identified three main factors that have an impact on NFB efficacy: first, a more intensive treatment, but not treatment duration, is associated with higher efficacy; second, teachers report a lower improvement compared to parents; third, using high-quality EEG equipment improves the effectiveness of the NFB treatment. The identification of biases relating to an appropriate technical implementation of NFB certainly supports the efficacy of NFB as an intervention. The data presented also suggest that the probably blind assessment of teachers may not be considered a good proxy for blind assessments, therefore stressing the need for studies with placebo-controlled intervention as well as carefully reported neuromarker changes in relation to clinical response.
topic ADHD
neurofeedback
meta-analysis
analysis of bias
EEG
url https://www.frontiersin.org/article/10.3389/fpsyt.2019.00035/full
work_keys_str_mv AT aurorebussalb clinicalandexperimentalfactorsinfluencingtheefficacyofneurofeedbackinadhdametaanalysis
AT aurorebussalb clinicalandexperimentalfactorsinfluencingtheefficacyofneurofeedbackinadhdametaanalysis
AT marcocongedo clinicalandexperimentalfactorsinfluencingtheefficacyofneurofeedbackinadhdametaanalysis
AT quentinbarthelemy clinicalandexperimentalfactorsinfluencingtheefficacyofneurofeedbackinadhdametaanalysis
AT davidojeda clinicalandexperimentalfactorsinfluencingtheefficacyofneurofeedbackinadhdametaanalysis
AT ericacquaviva clinicalandexperimentalfactorsinfluencingtheefficacyofneurofeedbackinadhdametaanalysis
AT richarddelorme clinicalandexperimentalfactorsinfluencingtheefficacyofneurofeedbackinadhdametaanalysis
AT louismayaud clinicalandexperimentalfactorsinfluencingtheefficacyofneurofeedbackinadhdametaanalysis
_version_ 1725402506711793664